Eli Lilli and Novo Nordisk have actually formerly offered arise from stage 3 research studies with their tablet variations.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/viking-therapeutics-weight-loss-pill-disappoints-in-phase-2/
Viking Therapeutics’ weight-loss pill disappoints in phase 2
赞 (0)
关于作者
Navamedic’s obesity business declined in year’s first half
下一篇
21 8 月, 2025
相关推荐
-
IAB Tech Lab introduces new CTV ad formats, updates programmatic guidance
The brand new CTV Advert Portfolio and up to date programmatic information purpose to streamline how rising advert codecs are outlined, transacted, and scaled throughout platforms.…
-
Retailers like Kroger and Lowe’s test AI agents without handing control to Google
Stores are beginning to challenge a trouble that rests behind much of the buzz around AI buying: as consumers transform to chatbots and automated aides to choose what to purchase, …
-
A Pharma Giant Invests in the Future of Tech for Managing the Cold Chain
If you’re aiming to obtain a peek right into the future of modern technology for handling the pharmaceutical cool chain, focus on where financiers are positioning their wager…
-
Video Friday: Jet-Powered Humanoid Robot Lifts Off
Video Clip Friday is your once a week choice of remarkable robotics video clips, gathered by your good friends at IEEE Range robotics. We likewise publish a regular schedule of upc…
-
Chinese Supplier to Assume Control of Roomba Parent Company
The Roomba manufacturer’s financial debts consist of $100 million to Chinese robotics producer Picea, and $3.4 million to united state Traditions and Boundary Defense for ove…
